Prepared by R.R. Donnelley Financial -- FORM 8-K

8-K 1 d8k.htm FORM 8-K Prepared by R.R. Donnelley Financial -- FORM 8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) September 10, 2002

SALIX PHARMACEUTICALS, LTD.

(Exact name of registrant as specified in its charter)

Delaware		000-23265		94-3267443
(State or other jurisdiction of incorporation)		(Commission file Number)		(IRS Employer ID Number)

8540 Colonnade Center Drive, Suite 501, Raleigh, North Carolina		27615
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code (919) 862-1000

Item 5. Other Events and Regulation FD Disclosure

Salix Pharmaceuticals, Ltd. issued a press release on September 10, 2002, announcing that it will present at the Bear Stearns 15th Annual Healthcare Conference on Tuesday, September 17, 2002, at 2:00 p.m. EDT. A copy of this press release is attached as an exhibit.

Item 7. Financial Statements and Exhibits

99.1

Press Release dated September 10, 2002

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SALIX PHARMACEUTICALS, LTD.

By:		/s/ ADAM C. DERBYSHIRE
		Adam C. Derbyshire Vice President and Chief Financial Officer

Date: September 10, 2002